RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis

by Alicia K. Morgans, Matthew R. Smith
Published 2011-01-01

Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy∗

by Charles J. Ryan, MD, Alicia K. Morgans, MD, MPH
Published 2020-03-01

Patient expectations of benefit from systemic treatments for metastatic prostate cancer

by Laura B. Oswald, Rachel Kasimer, Katherine Rappazzo, Angela J. Fought, David F. Penson, Alicia K. Morgans
Published 2020-02-01

Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer’s Disease

by Jessie S. Carr, Luke W. Bonham, Luke W. Bonham, Luke W. Bonham, Alicia K. Morgans, Charles J. Ryan, Jennifer S. Yokoyama, Ethan G. Geier, Alzheimer’s Disease Neuroimaging Initiative
Published 2018-08-01

Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling

by Peter J. Siska, Romany A. N. Johnpulle, Alice Zhou, Jennifer Bordeaux, Ju Young Kim, Bashar Dabbas, Naveen Dakappagari, Jeffrey C. Rathmell, W. Kimryn Rathmell, Alicia K. Morgans, Justin M. Balko, Douglas B. Johnson
Published 2017-04-01